HS
Harish Sunderlal Panpalia
About Harish Sunderlal Panpalia
Data last updated:
Harish Sunderlal Panpalia is a Director at Parnax Lab Limited (since 2023) and Director at Naxpar Pharma Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹373 Cr; the largest is Parnax Lab Limited at ₹189 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parnax Lab Limited L36912MH1982PLC027925 | Director | 11 Aug 2023 | 1982 | ₹189 Cr (FY 2025) | Active |
| Naxpar Pharma Private Limited U52310MH2004PTC144449 | Director | 11 Aug 2023 | 2004 | ₹184 Cr (FY 2025) | Active |
Board colleagues of Harish Sunderlal Panpalia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ami Mihir Shah | 03101049 | Parnax Lab Limited | Director |
| Binoy Baiju Shah | 00440880 | Parnax Lab Limited | Director |
| Binoy Baiju Shah | Parnax Lab Limited | Cfo | |
| Mihir Prakash Shah | 00387912 | Parnax Lab Limited , Naxpar Pharma Private Limited | Managing Director |
| Mihir Prakash Shah | Parnax Lab Limited | Ceo | |
| Preet Vijay Kukreja | Parnax Lab Limited | Company Secretary | |
| Vijaykumar Shivaji Ayare | 06383445 | Parnax Lab Limited | Director |
| Yogesh Kantilal Varia | 09186184 | Parnax Lab Limited , Naxpar Pharma Private Limited | Director |
| Baiju Mahasukhlal Shah | 00440806 | Naxpar Pharma Private Limited | Whole-Time Director |
| Prakash Mahasukhlal Shah | 00440980 | Naxpar Pharma Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harish Sunderlal Panpalia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harish Sunderlal Panpalia
Harish Sunderlal Panpalia currently holds 2 directorships: Parnax Lab Limited (Director, since 11 Aug 2023, revenue ₹189 Cr (FY 2025)); Naxpar Pharma Private Limited (Director, since 11 Aug 2023, revenue ₹184 Cr (FY 2025)).
Harish Sunderlal Panpalia was first appointed on 11 Aug 2023 as Director at Parnax Lab Limited.
The 2 current companies of Harish Sunderlal Panpalia that report revenue have a combined latest revenue of ₹373 Cr: Parnax Lab Limited ₹189 Cr (FY 2025); Naxpar Pharma Private Limited ₹184 Cr (FY 2025).
The current boards of Harish Sunderlal Panpalia's companies include Ami Mihir Shah (Parnax Lab Limited), Binoy Baiju Shah (Parnax Lab Limited), Binoy Baiju Shah (Parnax Lab Limited), Mihir Prakash Shah (Parnax Lab Limited), Mihir Prakash Shah (Parnax Lab Limited), Preet Vijay Kukreja (Parnax Lab Limited), among others.